Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for fostamatinib (compound)
Most Correlated Studies
- Liver cancer Huh7 cells sorafenib resistant treated with fostamatinib
- L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
- L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
- L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Most Relevant Literature
- A proof-of-concept open-label clinical trial of spleen tyrosine kinase antagonism using fostamatinib…
- Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thromb…
- Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3,…
- Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivat…
- Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, o…
Most Relevant Clinical Trials
- Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.
- Fostamatinib for Hospitalized Adults With COVID-19
- Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer
- A Single and Multiple Dose Study to Assess Blood and Urine Drug Levels of Fostamatinib in Healthy Ja…
- Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immun…
